Skip to main content
INBX logo

INBX

Inhibrx Biosciences, Inc.
$97.58 +2.64 (+2.78%) At close · Jul 2
Market Cap
$1.43B
Shares
14,671,186

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 138
Total Value: $875,433,930
Total Shares: 13,021,408
Showing 1–100 of 148 holdings by value · page 1 of 2

Institutional Ownership Trend

9 quarters

Holder Concentration

Across 137 13F filers
Top Holder
11.1%
Jun 2024 → Mar 2026 · range 10.4% – 19.4%
of institutional value
Top 5
47.4%
Jun 2024 → Mar 2026 · range 43.7% – 55.1%
of institutional value
Top 10
67.6%
Jun 2024 → Mar 2026 · range 62.0% – 76.8%
of institutional value
HHI
592
Jun 2024 → Mar 2026 · range 535 – 786
Broadly held
Showing 100 of 148
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 2007919 CUSIP 45720N103 13F (30d) 2 filings 2 filers Visit website